Surrozen, Inc. (SRZN)
Market: NASD |
Currency: USD
Address: 171 Oyster Point Boulevard
Surrozen, Inc., a clinical stage biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair. The company is developing antibody-based therapeutics which targets various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system. Its products in pipeline include SZN-043, a hepatocyte-specific R-spondin mimetic bispecific fusion protein, which is in Phase 1b clinical trial for the treatment of severe liver diseases, including alcohol-associated hepatitis. The company develops SZN-413, a Fzd4 targeted bi-specific antibody for the treatment of retinal vascular associated diseases. Surrozen, Inc. has collaboration and license agreement with Boehringer Ingelheim International GmbH to research, develop, and commercialize Fzd4 bi-specific antibodies. Surrozen, Inc. is based in South San Francisco, California.
Show more
📈 Surrozen, Inc. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$37.00
-
Upside/Downside from Analyst Target:
273.74%
-
Broker Call:
4
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
<0%
-
Net Income Growth Range (1Y):
<0%
-
Revenue Growth Range (1Y):
-
💰 Dividend History
| Year |
Annual Yield (%) |
Total Amount |
Current Yield (%) |
Ex Date |
Pay Date |
Particulars |
| 2023 |
- |
$0.066667 |
- |
2023-12-14 |
- |
Stock split |
|
Total Amount for 2023: $0.066667 |
📅 Earnings & EPS History for Surrozen, Inc.
| Date | Reported EPS |
|---|
| 2025-05-09 | -7.43 |
| 2025-03-31 | -9.1 |
| 2024-11-06 | -0.44 |
| 2024-08-12 | -1.54 |
| 2024-08-11 | -1.54 |
| 2024-05-08 | -4.24 |
| 2024-05-07 | -4.24 |
| 2024-04-08 | -4.41 |
| 2024-04-07 | -4.41 |
| 2023-11-08 | -0.34 |
| 2023-11-07 | -0.34 |
| 2023-08-09 | -0.31 |
| 2023-08-08 | -0.31 |
| 2023-05-10 | -0.48 |
| 2023-05-09 | -0.48 |
| 2023-03-22 | -0.03 |
| 2023-03-21 | -0.03 |
| 2022-11-14 | -0.38 |
| 2022-11-13 | -0.38 |
| 2022-08-11 | -0.4 |
| 2022-08-10 | -0.4 |
| 2022-05-11 | -0.23 |
| 2022-05-10 | -0.23 |
| 2022-03-24 | -0.6 |
| 2022-03-23 | -0.6 |
| 2021-11-15 | -0.51 |
| 2021-11-14 | -0.51 |
| 2021-08-06 | - |
| 2021-08-05 | - |
| 2021-07-15 | - |
| 2021-07-14 | - |
📰 Related News & Research
No related articles found for "surrozen inc".
